TrialESMO open2022

A phase I/II study of arfolitixorin and 5-fluorouracil in combination with oxaliplatin (plus or minus bevacizumab) or irinotecan in metastatic colorectal cancer.

G Carlsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.